The Pharmaceuticals UltraSector ProFund seeks daily investment results, before fees and expenses, that are 1.5x the return of the Dow Jones U.S. PharmaceuticalsSM Index (the "Index") for a single day.
| Investor Class | Service Class | |
|---|---|---|
| Ticker | PHPIX | PHPSX |
| CUSIP | 743185423 | 743185415 |
| Fund Number | 047 | 077 |
| Inception Date | 6/28/2000 | |
| Fund Group | Sector ProFunds - UltraSector | |
| Limits On Exchanges | None |
| Minimum Investment | |
| Individual Investor | $15,000 |
| Financial Professionals | $5,000 |
| Class | NAV | % Change | $ Change | |
|---|---|---|---|---|
| Investor | $16.25 | 0.00% | $0.00 | NAV History |
| Service | $15.26 | 0.00% | $0.00 | NAV History |
|
|
||||
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. For standardized returns year-to-date and as of the most recent calendar quarter-end, see performance Returns include the reinvestment of dividends and capital gains.
Returns include the reinvestment of dividends and capital gains.
| YTD (as of 5/17/2013) | 31.05% |
| Average Annual One Year | 37.59% |
| Average Annual Three Year | 21.76% |
| Average Annual Five Year | 13.84% |
| Average Annual Ten Year | 4.56% |
| Average Annual Since Inception | -1.39% |
| Cumulative Since Inception | -16.30% |
| Gross Expense Ratio | 2.44% |
| Net Expense Ratio | 1.73% |
All data, unless otherwise noted, is as of 3/31/2013 and for Investor Class Shares only and is subject to change.
The Index (Bloomberg symbol: DJUSPR) measures the performance of the pharmaceuticals sector of the U.S. equity market. Component companies include, among others, the makers of prescription and over-the-counter drugs, such as birth control pills, vaccines, aspirin and cold remedies. It is not possible to invest directly in an index.
| Total Index Companies | 24 |
| Average Index Market Capitalization | 35.79 billion |
| Top 10 Index Companies | Weight |
|---|---|
| Johnson & Johnson | 26.53% |
| Pfizer Inc. | 24.15% |
| Merck & Co Inc. | 15.56% |
| Bristol-Myers Squibb Co. | 7.85% |
| Eli Lilly and Co. | 6.60% |
| Abbott Laboratories | 6.46% |
| Allergan Inc. | 4.00% |
| Actavis Inc. | 1.37% |
| Mylan Inc. | 1.33% |
| Perrigo Co. | 1.22% |
Narrowly focused investments typically exhibit higher volatility.